alecensa - alectinib hydrochloride capsule
(Alectinib Hydrochloride)Genentech, Inc.
Usage: Alecensa treats adult patients with ALK-positive non-small cell lung cancer (NSCLC): as adjuvant therapy after tumor resection (tumors 4 cm or larger, or node-positive), and for metastatic ALK-positive NSCLC. ALK-positive status must be confirmed by an FDA-approved test.